These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 18840579)
21. [Anesthetic management for a patient with anti-phospholipid antigen syndrome]. Ando Y; Nagano K; Morita S; Itoh H; Fukushima Y Masui; 2009 Aug; 58(8):1007-9. PubMed ID: 19702220 [TBL] [Abstract][Full Text] [Related]
22. Acute myocardial infarction requiring mechanical bridge to transplantation in a patient with undiagnosed anti-phospholipid antibody syndrome. Reade CC; Morris RJ; Acker MA; Jessup M; Banbury MK; Woo YJ J Heart Lung Transplant; 2008 Jun; 27(6):682-4. PubMed ID: 18503970 [TBL] [Abstract][Full Text] [Related]
23. Use of pediatric Berlin Heart EXCOR biventricular device as a bridge to retransplantation in a 10-month-old infant with acute graft failure after cardiac transplantation. Krokstrom AK; Higgins T; Johansson S; Jögi P ASAIO J; 2009; 55(5):525-6. PubMed ID: 19730011 [TBL] [Abstract][Full Text] [Related]
24. Heart Transplantation in an Era of Mechanical Circulatory Support. Kwak J; Majewski M; LeVan PT J Cardiothorac Vasc Anesth; 2018 Feb; 32(1):19-31. PubMed ID: 29132806 [No Abstract] [Full Text] [Related]
25. European experience of DuraHeart magnetically levitated centrifugal left ventricular assist system. Morshuis M; El-Banayosy A; Arusoglu L; Koerfer R; Hetzer R; Wieselthaler G; Pavie A; Nojiri C Eur J Cardiothorac Surg; 2009 Jun; 35(6):1020-7; discussion 1027-8. PubMed ID: 19233673 [TBL] [Abstract][Full Text] [Related]
26. Association Between Hematologic and Inflammatory Markers and 31 Thrombotic and Hemorrhagic Events in Berlin Heart Excor Patients. Iyengar A; Hung ML; Asanad K; Kwon OJ; Jackson NJ; Reemtsen BL; Federman MD; Biniwale RM Pediatr Cardiol; 2017 Apr; 38(4):770-777. PubMed ID: 28184979 [TBL] [Abstract][Full Text] [Related]
27. Thromboelastometry in patients with severe sepsis and disseminated intravascular coagulation. Sivula M; Pettilä V; Niemi TT; Varpula M; Kuitunen AH Blood Coagul Fibrinolysis; 2009 Sep; 20(6):419-26. PubMed ID: 19581801 [TBL] [Abstract][Full Text] [Related]
28. Low thromboembolic risk for patients with the Heartmate II left ventricular assist device. John R; Kamdar F; Liao K; Colvin-Adams M; Miller L; Joyce L; Boyle A J Thorac Cardiovasc Surg; 2008 Nov; 136(5):1318-23. PubMed ID: 19026822 [TBL] [Abstract][Full Text] [Related]
29. Heparin Anticoagulation Monitoring in Patients Supported by Ventricular Assist Devices. Schweiger M; Hübler M; Albisetti M ASAIO J; 2015; 61(5):487-8. PubMed ID: 26207782 [No Abstract] [Full Text] [Related]
30. Focus on mechanical assist devices for the treatment of heart failure. Poole-Wilson PA Nat Clin Pract Cardiovasc Med; 2008 Feb; 5(2):59. PubMed ID: 18223539 [No Abstract] [Full Text] [Related]
37. Activation of endothelial and coagulation systems in left ventricular assist device recipients. John R; Panch S; Hrabe J; Wei P; Solovey A; Joyce L; Hebbel R Ann Thorac Surg; 2009 Oct; 88(4):1171-9. PubMed ID: 19766802 [TBL] [Abstract][Full Text] [Related]
38. Can mean platelet volume be used as a biomarker of pathological fibrin clot strength related to obesity? Taura P; Polanco-Garcia M; Rivas E; Blasi A; Lacy AM Thromb Res; 2016 Dec; 148():56-58. PubMed ID: 27780114 [No Abstract] [Full Text] [Related]
39. Incidence and risk factors of early thromboembolic events after mechanical heart valve replacement in patients treated with intravenous unfractionated heparin. Allou N; Piednoir P; Berroëta C; Provenchère S; Ibrahim H; Baron G; Montravers P; Iung B; Philip I; Ajzenberg N Heart; 2009 Oct; 95(20):1694-700. PubMed ID: 19482850 [TBL] [Abstract][Full Text] [Related]
40. The future is here: ventricular assist devices for the failing heart. Alba AC; Delgado DH Expert Rev Cardiovasc Ther; 2009 Sep; 7(9):1067-77. PubMed ID: 19764860 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]